Autoimmune hemolityc anemia concomitant with sequential autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Hashimoto's thyroiditis: a new entity of autoimmune polyendocrine syndrome.
Gentile
M
M
Verta
M
M
Vigna
E
E
Lucia
E
E
Mazzone
C
C
Perugini
D
D
Gentile
C
C
Bisconte
M G
MG
Romeo
F
F
Leo
P
P
Betterle
C
C
Morabito
F
F
D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D019819:Budesonide / Q000008:administration & dosage; D005260:Female; D050031:Hashimoto Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D019693:Hepatitis, Autoimmune / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008875:Middle Aged; D016884:Polyendocrinopathies, Autoimmune / Q000175:diagnosis* / Q000188:drug therapy; D013577:Syndrome; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage
D000893:Anti-Inflammatory Agents; D019819:Budesonide; D014580:Ursodeoxycholic Acid